{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:44:58Z","timestamp":1790700298621,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,24]],"date-time":"2012-04-24T00:00:00Z","timestamp":1335225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nutr"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00394-012-0357-x","type":"journal-article","created":{"date-parts":[[2012,4,23]],"date-time":"2012-04-23T12:54:11Z","timestamp":1335185651000},"page":"547-557","source":"Crossref","is-referenced-by-count":40,"title":["LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia"],"prefix":"10.1007","volume":"52","author":[{"given":"Nicolas","family":"Ogier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jos\u00e8phe","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Georg\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cilia","family":"Mallmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Maraninchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Lescuyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien L.","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Cardinault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,24]]},"reference":[{"key":"357_CR1","doi-asserted-by":"crossref","first-page":"91G","DOI":"10.1016\/0002-9149(87)90165-2","volume":"59","author":"PW Wilson","year":"1987","unstructured":"Wilson PW, Castelli WP, Kannel WB (1987) Coronary risk prediction in adults (the Framingham Heart Study). Am J Cardiol 59:91G\u201394G","journal-title":"Am J Cardiol"},{"key":"357_CR2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2005.05.085","volume":"46","author":"JG Robinson","year":"2005","unstructured":"Robinson JG, Smith B, Maheshwari N, Schrott H (2005) Pleiotropic effects of statins: benefit beyond cholesterol reduction? A meta-regression analysis. J Am Coll Cardiol 46:1855\u20131862","journal-title":"J Am Coll Cardiol"},{"key":"357_CR3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","volume":"366","author":"C Baigent","year":"2005","unstructured":"Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366:1267\u20131278","journal-title":"Lancet"},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1476-511X-9-71","volume":"9","author":"D Vondrakova","year":"2010","unstructured":"Vondrakova D, Ostadal P, Kruger A (2010) Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome. Lipids Health Dis 9:71","journal-title":"Lipids Health Dis"},{"key":"357_CR5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archinte.165.3.281","volume":"165","author":"JP Kelly","year":"2005","unstructured":"Kelly JP, Kaufman DW, Kelley K, Rosenberg L, Anderson TE, Mitchell AA (2005) Recent trends in use of herbal and other natural products. Arch Intern Med 165:281\u2013286","journal-title":"Arch Intern Med"},{"key":"357_CR6","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486\u20132497","journal-title":"JAMA"},{"key":"357_CR7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2010.07.001","volume":"4","author":"PS Nijjar","year":"2010","unstructured":"Nijjar PS, Burke FM, Bloesch A, Rader DJ (2010) Role of dietary supplements in lowering low-density lipoprotein cholesterol: a review. J Clin Lipidol 4:248\u2013258","journal-title":"J Clin Lipidol"},{"key":"357_CR8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/14017431003624123","volume":"44","author":"MP Bogsrud","year":"2010","unstructured":"Bogsrud MP, Ose L, Langslet G, Ottestad I, Strom EC, Hagve TA, Retterstol K (2010) HypoCol (red yeast rice) lowers plasma cholesterol: a randomized placebo controlled study. Scand Cardiovasc J 44:197\u2013200","journal-title":"Scand Cardiovasc J"},{"key":"357_CR9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/eje.1.02012","volume":"153","author":"CC Lin","year":"2005","unstructured":"Lin CC, Li TC, Lai MM (2005) Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol 153:679\u2013686","journal-title":"Eur J Endocrinol"},{"key":"357_CR10","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","volume":"69","author":"D Heber","year":"1999","unstructured":"Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL (1999) Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr 69:231\u2013236","journal-title":"Am J Clin Nutr"},{"key":"357_CR11","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/HJR.0b013e32801da137","volume":"14","author":"CF Huang","year":"2007","unstructured":"Huang CF, Li TC, Lin CC, Liu CS, Shih HC, Lai MM (2007) Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients. Eur J Cardiovasc Prev Rehabil 14:438\u2013440","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"357_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1749-8546-1-4","volume":"1","author":"J Liu","year":"2006","unstructured":"Liu J, Zhang J, Shi Y, Grimsgaard S, Alraek T, Fonnebo V (2006) Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials. Chin Med 1:4","journal-title":"Chin Med"},{"key":"357_CR13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/107555301750164181","volume":"7","author":"D Heber","year":"2001","unstructured":"Heber D, Lembertas A, Lu QY, Bowerman S, Go VL (2001) An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med 7:133\u2013139","journal-title":"J Altern Complement Med"},{"key":"357_CR14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1592\/phco.25.2.171.56942","volume":"25","author":"JT Chen","year":"2005","unstructured":"Chen JT, Wesley R, Shamburek RD, Pucino F, Csako G (2005) Meta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy 25:171\u2013183","journal-title":"Pharmacotherapy"},{"key":"357_CR15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1067\/mhj.2002.119997","volume":"143","author":"I Gouni-Berthold","year":"2002","unstructured":"Gouni-Berthold I, Berthold HK (2002) Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J 143:356\u2013365","journal-title":"Am Heart J"},{"key":"357_CR16","doi-asserted-by":"crossref","unstructured":"Wider B, Pittler MH, Thompson-Coon J, Ernst E (2009) Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst Rev CD003335","DOI":"10.1002\/14651858.CD003335.pub2"},{"key":"357_CR17","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1515\/CCLM.1999.118","volume":"37","author":"M Kaplan","year":"1999","unstructured":"Kaplan M, Aviram M (1999) Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 37:777\u2013787","journal-title":"Clin Chem Lab Med"},{"key":"357_CR18","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/01.ATV.20.10.2243","volume":"20","author":"S Toshima","year":"2000","unstructured":"Toshima S, Hasegawa A, Kurabayashi M, Itabe H, Takano T, Sugano J, Shimamura K, Kimura J, Michishita I, Suzuki T, Nagai R (2000) Circulating oxidized low density lipoprotein levels. A biochemical risk marker for coronary heart disease. Arterioscler Thromb Vasc Biol 20:2243\u20132247","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"357_CR19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s11883-004-0089-3","volume":"6","author":"PE Bowen","year":"2004","unstructured":"Bowen PE, Borthakur G (2004) Postprandial lipid oxidation and cardiovascular disease risk. Curr Atheroscler Rep 6:477\u2013484","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl 5","key":"357_CR20","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1289\/ehp.98106s51229","volume":"106","author":"FJ Romero","year":"1998","unstructured":"Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Marin N, Roma J (1998) Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 106(Suppl 5):1229\u20131234","journal-title":"Environ Health Perspect"},{"key":"357_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ajcn\/64.2.190","volume":"64","author":"KG Losonczy","year":"1996","unstructured":"Losonczy KG, Harris TB, Havlik RJ (1996) Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64:190\u2013196","journal-title":"Am J Clin Nutr"},{"key":"357_CR22","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJM199305203282004","volume":"328","author":"EB Rimm","year":"1993","unstructured":"Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC (1993) Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328:1450\u20131456","journal-title":"N Engl J Med"},{"key":"357_CR23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM199305203282003","volume":"328","author":"MJ Stampfer","year":"1993","unstructured":"Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC (1993) Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 328:1444\u20131449","journal-title":"N Engl J Med"},{"key":"357_CR24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499\u2013502","journal-title":"Clin Chem"},{"key":"357_CR25","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1001\/jama.288.20.2569","volume":"288","author":"FB Hu","year":"2002","unstructured":"Hu FB, Willett WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288:2569\u20132578","journal-title":"JAMA"},{"key":"357_CR26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1001\/archinternmed.2009.38","volume":"169","author":"A Mente","year":"2009","unstructured":"Mente A, de Koning L, Shannon HS, Anand SS (2009) A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 169:659\u2013669","journal-title":"Arch Intern Med"},{"key":"357_CR27","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","volume":"32","author":"Z Reiner","year":"2011","unstructured":"Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL (2011) ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J 32:1769\u20131818","journal-title":"Eur Heart J"},{"key":"357_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.atherosclerosis.2008.06.019","volume":"203","author":"CR Sirtori","year":"2009","unstructured":"Sirtori CR, Galli C, Anderson JW, Arnoldi A (2009) Nutritional and nutraceutical approaches to dyslipidemia and atherosclerosis prevention: focus on dietary proteins. Atherosclerosis 203:8\u201317","journal-title":"Atherosclerosis"},{"key":"357_CR29","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7164\/antibiotics.32.852","volume":"32","author":"A Endo","year":"1979","unstructured":"Endo A (1979) Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. J Antibiot (Tokyo) 32:852\u2013854","journal-title":"J Antibiot (Tokyo)"},{"key":"357_CR30","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","volume":"150","author":"DJ Becker","year":"2009","unstructured":"Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ (2009) Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Ann Intern Med 150:830\u2013839","journal-title":"Ann Intern Med"},{"key":"357_CR31","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1016\/j.lfs.2003.10.018","volume":"74","author":"M Journoud","year":"2004","unstructured":"Journoud M, Jones PJ (2004) Red yeast rice: a new hypolipidemic drug. Life Sci 74:2675\u20132683","journal-title":"Life Sci"},{"key":"357_CR32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.numecd.2009.10.015","volume":"21","author":"O Guardamagna","year":"2011","unstructured":"Guardamagna O, Abello F, Baracco V, Stasiowska B, Martino F (2011) The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. Nutr Metab Cardiovasc Dis 21:424\u2013429","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"357_CR33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2165\/00044011-200525110-00003","volume":"25","author":"Z Reiner","year":"2005","unstructured":"Reiner Z, Tedeschi-Reiner E, Romic Z (2005) Effects of rice policosanol on serum lipoproteins, homocysteine, fibrinogen and C-reactive protein in hypercholesterolaemic patients. Clin Drug Investig 25:701\u2013707","journal-title":"Clin Drug Investig"},{"key":"357_CR34","first-page":"43","volume":"21","author":"G Castano","year":"2001","unstructured":"Castano G, Mas R, Fernandez L, Illnait J, Gamez R, Alvarez E (2001) Effects of policosanol 20 versus 40\u00a0mg\/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study. Int J Clin Pharmacol Res 21:43\u201357","journal-title":"Int J Clin Pharmacol Res"},{"key":"357_CR35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/00044011-200323100-00003","volume":"23","author":"G Castano","year":"2003","unstructured":"Castano G, Fernandez L, Mas R, Illnait J, Mesa M, Fernandez JC (2003) Comparison of the effects of policosanol and atorvastatin on lipid profile and platelet aggregation in patients with dyslipidaemia and type 2 diabetes mellitus. Clin Drug Investig 23:639\u2013650","journal-title":"Clin Drug Investig"},{"key":"357_CR36","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4067\/S0034-98871999001000016","volume":"127","author":"H Prat","year":"1999","unstructured":"Prat H, Roman O, Pino E (1999) Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia. Rev Med Chil 127:286\u2013294","journal-title":"Rev Med Chil"},{"key":"357_CR37","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.106.107144","volume":"318","author":"DK Singh","year":"2006","unstructured":"Singh DK, Li L, Porter TD (2006) Policosanol inhibits cholesterol synthesis in hepatoma cells by activation of AMP-kinase. J Pharmacol Exp Ther 318:1020\u20131026","journal-title":"J Pharmacol Exp Ther"},{"key":"357_CR38","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","volume":"28","author":"G Marazzi","year":"2011","unstructured":"Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G (2011) Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther 28:1105\u20131113","journal-title":"Adv Ther"},{"key":"357_CR39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctim.2007.08.003","volume":"16","author":"F Francini-Pesenti","year":"2008","unstructured":"Francini-Pesenti F, Brocadello F, Beltramolli D, Nardi M, Caregaro L (2008) Sugar cane policosanol failed to lower plasma cholesterol in primitive, diet-resistant hypercholesterolaemia: a double blind, controlled study. Complement Ther Med 16:61\u201365","journal-title":"Complement Ther Med"},{"issue":"982","key":"357_CR40","first-page":"e981","volume":"152","author":"LX Cubeddu","year":"2006","unstructured":"Cubeddu LX, Cubeddu RJ, Heimowitz T, Restrepo B, Lamas GA, Weinberg GB (2006) Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. Am Heart J 152(982):e981\u2013e985","journal-title":"Am Heart J"},{"key":"357_CR41","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.295.19.2262","volume":"295","author":"HK Berthold","year":"2006","unstructured":"Berthold HK, Unverdorben S, Degenhardt R, Bulitta M, Gouni-Berthold I (2006) Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 295:2262\u20132269","journal-title":"JAMA"},{"key":"357_CR42","first-page":"1122","volume":"286","author":"R Gebhardt","year":"1998","unstructured":"Gebhardt R (1998) Inhibition of cholesterol biosynthesis in primary cultured rat hepatocytes by artichoke (Cynara scolymus L.) extracts. J Pharmacol Exp Ther 286:1122\u20131128","journal-title":"J Pharmacol Exp Ther"},{"key":"357_CR43","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.phymed.2008.03.001","volume":"15","author":"R Bundy","year":"2008","unstructured":"Bundy R, Walker AF, Middleton RW, Wallis C, Simpson HC (2008) Artichoke leaf extract (Cynara scolymus) reduces plasma cholesterol in otherwise healthy hypercholesterolemic adults: a randomized, double blind placebo controlled trial. Phytomedicine 15:668\u2013675","journal-title":"Phytomedicine"},{"key":"357_CR44","first-page":"260","volume":"50","author":"W Englisch","year":"2000","unstructured":"Englisch W, Beckers C, Unkauf M, Ruepp M, Zinserling V (2000) Efficacy of Artichoke dry extract in patients with hyperlipoproteinemia. Arzneimittelforschung 50:260\u2013265","journal-title":"Arzneimittelforschung"},{"key":"357_CR45","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","volume":"104","author":"CK Glass","year":"2001","unstructured":"Glass CK, Witztum JL (2001) Atherosclerosis. The road ahead. Cell 104:503\u2013516","journal-title":"Cell"},{"key":"357_CR46","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11883-003-0040-z","volume":"5","author":"LA Bazzano","year":"2003","unstructured":"Bazzano LA, Serdula MK, Liu S (2003) Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr Atheroscler Rep 5:492\u2013499","journal-title":"Curr Atheroscler Rep"},{"key":"357_CR47","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/jnci\/djh296","volume":"96","author":"HC Hung","year":"2004","unstructured":"Hung HC, Joshipura KJ, Jiang R, Hu FB, Hunter D, Smith-Warner SA, Colditz GA, Rosner B, Spiegelman D, Willett WC (2004) Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst 96:1577\u20131584","journal-title":"J Natl Cancer Inst"},{"key":"357_CR48","unstructured":"French Study (2009) Etude individuelle nationale des consommations alimentation: INCA2, AFSSA"},{"key":"357_CR49","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1734-1140(09)70146-X","volume":"61","author":"A Nagila","year":"2009","unstructured":"Nagila A, Permpongpaiboon T, Tantrarongroj S, Porapakkham P, Chinwattana K, Deakin S, Porntadavity S (2009) Effect of atorvastatin on paraoxonase 1 (PON1) and oxidative status. Pharmacol Rep 61:892\u2013898","journal-title":"Pharmacol Rep"},{"key":"357_CR50","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jama.285.9.1178","volume":"285","author":"EA Meagher","year":"2001","unstructured":"Meagher EA, Barry OP, Lawson JA, Rokach J, Fitzgerald GA (2001) Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285:1178\u20131182","journal-title":"JAMA"}],"container-title":["European Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-012-0357-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00394-012-0357-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00394-012-0357-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T10:25:19Z","timestamp":1594031119000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00394-012-0357-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,24]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1007\/s00394-012-0357-x","relation":{},"ISSN":["1436-6207","1436-6215"],"issn-type":[{"value":"1436-6207","type":"print"},{"value":"1436-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,24]]}}}